Application of an irreversible opiate antagonist (β-FNA, β-funal-trexamine) to demonstrate dynorphin selectivity for K-opioid sites
- 8 November 1982
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 31 (22), 2409-2416
- https://doi.org/10.1016/0024-3205(82)90744-5
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Isolation and structure of dynorphin, an opioid peptide, from porcine duodenumNature, 1982
- The preference of putative pro-enkephalins for different types of opiate receptorsLife Sciences, 1981
- Rabbit vas deferens: A specific bioassay for opioid κ-receptor agonistsEuropean Journal of Pharmacology, 1981
- Dynorphin interaction at the κ-opiate siteEuropean Journal of Pharmacology, 1981
- Demonstration of a specific dynorphin receptor in guinea pig ileum myenteric plexusNature, 1981
- The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexoneEuropean Journal of Pharmacology, 1981
- Levels of immunoreactive dynorphin in brain and pituitary of Brattleboro ratsNeuroscience Letters, 1980
- Highly specific opiate receptors for dynorphin-(1–13) in the mouse vas deferensEuropean Journal of Pharmacology, 1980
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980
- Synthesis and pharmacologic characterization of an alkylating analog chlornaltrexamine, of naltrexone with ultralong-lasting narcotic antagonist propertiesJournal of Medicinal Chemistry, 1979